Citizens Inc
$ 5.62
-0.53%
24 Feb - close price
- Market Cap 282,668,000 USD
- Current Price $ 5.62
- High / Low $ 5.70 / 5.48
- Stock P/E 26.76
- Book Value 4.49
- EPS 0.21
- Next Earning Report 2026-03-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE 0.05 %
- 52 Week High 6.40
- 52 Week Low 2.90
About
Citizens, Inc., offers life insurance products in the United States and internationally. The company is headquartered in Austin, Texas.
Analyst Target Price
$6.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-07 | 2025-08-07 | 2025-05-05 | 2025-03-12 | 2024-11-04 | 2024-08-06 | 2024-05-07 | 2024-03-06 | 2023-11-06 | 2023-08-04 | 2023-05-08 | 2023-03-13 |
| Reported EPS | 0.07 | 0.13 | 0.02 | 0.1509 | 0.05 | 0.08 | 0.0898 | 0.2168 | 0.05 | 0.1212 | 0.1 | 0.0677 |
| Estimated EPS | 0.09 | 0.055 | 0.05 | 0.09 | 0.08 | 0.06 | 0.06 | 0.21 | None | None | None | None |
| Surprise | -0.02 | 0.075 | -0.03 | 0.0609 | -0.03 | 0.02 | 0.0298 | 0.0068 | 0 | 0 | 0 | 0 |
| Surprise Percentage | -22.2222% | 136.3636% | -60% | 67.6667% | -37.5% | 33.3333% | 49.6667% | 3.2381% | None% | None% | None% | None% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-12 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.08 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CIA
2026-01-29 13:01:06
Citizens, Inc. (NYSE: CIA), a financial services company, announced its participation in Noble Capital Markets' Emerging Growth Virtual Conference on February 4 and 5, 2026. Management will present and be available for one-on-one meetings. A fireside chat webcast with management will also be held on February 4, 2026, at 2:00 PM ET.
2026-01-16 03:57:20
Citizens, Inc. (NYSE:CIA) has a high P/E ratio of 24.6x compared to the broader market, despite recent earnings decline of 51% last year and 79% over three years. However, analysts forecast a 29% EPS growth for the coming year, significantly outpacing the market's 16% expectation. This anticipated strong future growth is cited as the reason investors are willing to pay a premium for the stock, maintaining its high P/E.
2025-12-06 02:11:28
Citizens, Inc. (NYSE:CIA) has seen a significant 102% increase in share price over the past three years, despite a 40% annualized decline in earnings per share during the same period. While recent share performance has been soft, the long-term returns have been strong. The article suggests looking beyond just earnings growth for a complete understanding of the company's performance, noting that insiders have been buying shares.
2025-12-05 00:09:37
Citizens, Inc. has announced its participation in two upcoming virtual investor conferences: the Sidoti Virtual Conference on December 10 and 11, 2025, and the Emerging Growth Virtual Conference on December 11, 2025. Management will present at both events, with webcasts of their presentations available on the company's Investor Relations website. Citizens, Inc. (NYSE: CIA) is a diversified financial services company specializing in life, living benefits, and final expense insurance.
2025-11-29 01:07:32
Citizens Inc. (CIA) reported mixed financial results for Q3 2025. While total revenues saw a slight increase to $183.5 million for the nine months ending September 30, 2025, net income decreased to $7.3 million due to challenges in investment-related gains and increased insurance benefits. The company's total assets grew to $1.74 billion, driven by increases in fixed maturity securities and deferred policy acquisition costs.
2025-11-07 10:25:00
Citizens, Inc. achieved a new 52-week high of $6.25, marking a 90.4% increase over the past year and significantly outperforming the S&P 500. The microcap insurance company has a market capitalization of $288 million, with moderate valuation metrics including a P/E ratio of 23.00 and a price-to-book ratio of 1.26. Despite no dividend yield, it shows an ROE of 4.91%.
